PL2249842T3 - Zastosowanie 25-hydroksy-witaminy D3 i witaminy D do oddziaływania na fizjologię ludzkich mięśni - Google Patents

Zastosowanie 25-hydroksy-witaminy D3 i witaminy D do oddziaływania na fizjologię ludzkich mięśni

Info

Publication number
PL2249842T3
PL2249842T3 PL09710537T PL09710537T PL2249842T3 PL 2249842 T3 PL2249842 T3 PL 2249842T3 PL 09710537 T PL09710537 T PL 09710537T PL 09710537 T PL09710537 T PL 09710537T PL 2249842 T3 PL2249842 T3 PL 2249842T3
Authority
PL
Poland
Prior art keywords
vitamin
hydroxy
human muscle
affect human
muscle physiology
Prior art date
Application number
PL09710537T
Other languages
English (en)
Other versions
PL2249842T5 (pl
Inventor
Neil Robert Buck
Wouter Claerhout
Bruno H. Leuenberger
Elisabeth Stoecklin
Kai Urban
Swen Wolfram
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40551381&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2249842(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of PL2249842T3 publication Critical patent/PL2249842T3/pl
Publication of PL2249842T5 publication Critical patent/PL2249842T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL09710537.3T 2008-02-13 2009-02-12 Zastosowanie 25-hydroksy-witaminy D3 i witaminy D do oddziaływania na fizjologię ludzkich mięśni PL2249842T5 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US2851008P 2008-02-13 2008-02-13
US3167108P 2008-02-26 2008-02-26
US3692408P 2008-03-14 2008-03-14
US3692808P 2008-03-15 2008-03-15
US12913908P 2008-06-06 2008-06-06
PCT/EP2009/051641 WO2009101137A1 (en) 2008-02-13 2009-02-12 Use of 25-hydroxy-vitamin d3 to affect human muscle physiology

Publications (2)

Publication Number Publication Date
PL2249842T3 true PL2249842T3 (pl) 2017-01-31
PL2249842T5 PL2249842T5 (pl) 2025-11-12

Family

ID=40551381

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09710537.3T PL2249842T5 (pl) 2008-02-13 2009-02-12 Zastosowanie 25-hydroksy-witaminy D3 i witaminy D do oddziaływania na fizjologię ludzkich mięśni

Country Status (13)

Country Link
US (3) US20110039810A1 (pl)
EP (1) EP2249842B2 (pl)
JP (1) JP5593550B2 (pl)
KR (1) KR101561717B1 (pl)
CN (2) CN107412237A (pl)
AU (1) AU2009214054B2 (pl)
BR (1) BRPI0907953A2 (pl)
EA (1) EA019837B1 (pl)
ES (1) ES2599761T5 (pl)
IL (1) IL207588A (pl)
MX (1) MX2010008904A (pl)
PL (1) PL2249842T5 (pl)
WO (1) WO2009101137A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2882048C (en) 2006-02-03 2020-03-24 Opko Renal, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
HUE037309T2 (hu) 2006-06-21 2018-08-28 Opko Ireland Global Holdings Ltd Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer
ES2401205T3 (es) 2007-04-25 2013-04-17 Cytochroma Inc. Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
WO2009047644A2 (en) 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
CA2683514C (en) 2007-04-25 2019-07-09 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
EP2011835A1 (en) 2007-07-06 2009-01-07 Chr. Hansen A/S A colouring composition comprising starch derivatives as a hydrocolloid
EP2249842B2 (en) 2008-02-13 2025-03-05 DSM IP Assets B.V. Use of 25-hydroxy-vitamin d3 and vitamin d to affect human muscle physiology
KR101685031B1 (ko) 2008-04-02 2016-12-09 사이토크로마 인코포레이티드 비타민 ｄ 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
PT2321273E (pt) * 2008-07-24 2014-12-29 Wisconsin Alumni Res Found Administração semanal de 25-hidroxi-vitamina d3 para manter concentração sanguínea elevada numa farmacocinética de estado estacionário
CN103037902A (zh) 2010-03-29 2013-04-10 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
JP2016518348A (ja) * 2013-03-27 2016-06-23 ディーエスエム アイピー アセッツ ビー．ブイ． 実行機能を増強するための２５−ヒドロキシビタミンｄ３の使用
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
EP4596045A3 (en) 2016-03-28 2025-10-15 EirGen Pharma Ltd. Methods of vitamin d treatment
CN108902985A (zh) * 2018-06-08 2018-11-30 唐飞 25-羟基维生素d3在制备保健食品中的应用
AU2019396829B2 (en) * 2018-12-11 2025-04-17 Myospots Australia Pty Ltd Adhesive pad
IT202100007655A1 (it) 2021-03-29 2022-09-29 Abiogen Pharma Spa Uso di colecalciferolo come coadiuvante nel trattamento di distrofie muscolari
JP2022185501A (ja) * 2021-06-02 2022-12-14 株式会社ダイセル 閉経後の女性の筋肉の重量を増加させるための組成物
CN114128763B (zh) * 2021-11-24 2024-02-27 北大荒完达山乳业股份有限公司 一种维生素d3营养强化剂及其制备方法和应用
CN116173217A (zh) * 2023-02-24 2023-05-30 浙江大学 维生素d受体激动剂在制备治疗运动神经元疾病产品中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US20020037279A1 (en) * 1996-09-13 2002-03-28 Herman H. Vandenburgh Delivery of bioactive compounds to an organism
US7632518B2 (en) * 2002-01-15 2009-12-15 Dsm Ip Assets B.V. 25-hydroxy vitamin D3 compositions
WO2005027650A1 (en) * 2003-09-22 2005-03-31 Dsm Ip Assets B.V. Vitamin containing pet food compositions
US7212141B2 (en) * 2005-07-11 2007-05-01 Intel Corporation Filter with gain
US20070122477A1 (en) 2005-10-12 2007-05-31 Cytochroma, Inc. Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency
ATE476104T1 (de) * 2005-11-25 2010-08-15 Dsm Ip Assets Bv Verwendung von 25-hydroxy-vitamin d3 zur verbesserung der vitalität von tieren
CA2882048C (en) † 2006-02-03 2020-03-24 Opko Renal, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
WO2009047644A2 (en) † 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
ES2401205T3 (es) * 2007-04-25 2013-04-17 Cytochroma Inc. Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
EP2249842B2 (en) 2008-02-13 2025-03-05 DSM IP Assets B.V. Use of 25-hydroxy-vitamin d3 and vitamin d to affect human muscle physiology
JP5910495B2 (ja) * 2009-06-11 2016-04-27 ディーエスエム アイピー アセッツ ビー．ブイ． 筋肉刺激剤としてのナイアシン及び／又はトリゴネリン
US8168611B1 (en) * 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation

Also Published As

Publication number Publication date
BRPI0907953A2 (pt) 2015-08-04
US20110039810A1 (en) 2011-02-17
WO2009101137A1 (en) 2009-08-20
EP2249842A1 (en) 2010-11-17
EP2249842B1 (en) 2016-07-27
IL207588A0 (en) 2010-12-30
EA019837B1 (ru) 2014-06-30
EA201001285A1 (ru) 2011-02-28
ES2599761T5 (en) 2025-06-18
US20160263128A1 (en) 2016-09-15
MX2010008904A (es) 2010-11-05
PL2249842T5 (pl) 2025-11-12
US20130150598A1 (en) 2013-06-13
AU2009214054A1 (en) 2009-08-20
KR20100117113A (ko) 2010-11-02
KR101561717B1 (ko) 2015-10-19
CN101951916A (zh) 2011-01-19
JP2011511828A (ja) 2011-04-14
EP2249842B2 (en) 2025-03-05
IL207588A (en) 2016-06-30
CN107412237A (zh) 2017-12-01
JP5593550B2 (ja) 2014-09-24
AU2009214054B2 (en) 2014-12-18
ES2599761T3 (es) 2017-02-03

Similar Documents

Publication Publication Date Title
PL2249842T5 (pl) Zastosowanie 25-hydroksy-witaminy D3 i witaminy D do oddziaływania na fizjologię ludzkich mięśni
IL219974A0 (en) Therapeutic compounds and related methods of use
EP2448581A4 (en) THERAPEUTIC COMPOSITIONS AND METHODS OF USE THEREOF
EP2219600A4 (en) TOPICAL COSMETIC SKIN COMPOSITIONS AND APPLICATION METHOD THEREFOR
PL2317878T3 (pl) Kompozycja odżywcza do poprawy funkcji mięśni i codziennej aktywności
IL234954A0 (en) Antibodies 1a–il and methods of use
EP2238969A4 (en) PREPARATION FOR EXTERNAL APPLICATION TO THE SKIN AND COSMETIC PREPARATION
ZA201302979B (en) Dianosis and treatment relating to th2 inhibition
IL226495A (en) Derivatives of the Terroylsulfonamides, their preparation and their application in human therapy
IL209528A (en) Ancestors of brown adipocyte cells in human skeletal muscle
IL207589A0 (en) Combination of vitamin d and 25-hydroxyvitamin d3
SI2424520T1 (sl) Uporaba večkrat nenasičenih maščobnih kislin za zdravljenje vnetja kože
EP2493550A4 (en) ELECTRO-OPTICAL FABRIC STIMULATOR AND METHOD OF USE THEREOF
PT2549995T (pt) Utilização de anatabina para tratar inflamação e métodos de sintetizar a anatabina
ZA201100166B (en) Spingosine 1 phosphate receptor modulators and their use to treat muscle inflammation
ZA201104743B (en) Topical herbal formulation for treatment of acne and skin disorders
SG10201505156QA (en) Use of caftaric acid and derivatives in food supplement for regulating skin pigmentation
IL211844A0 (en) Skin treatments containing carboxylic acid-substitiuted idebenone derivatives and methods of preparation and use thereof
EP2274325A4 (en) ANALOGUE OF HUMAN G-CSF AND METHOD OF MANUFACTURE AND APPLICATION THEREOF
EP2344191A4 (en) HUMAN PAPILLOMAVIRUS / LI-KEY HYBRIDS AND METHODS OF USE
IL214353A0 (en) Dimeric pyrrolopyrimidinedione and its use in therapy of respiratory diseases
PL2173356T5 (pl) Stosowanie 25-hydroksywitaminy d3 do zwiększania masy mięśniowej u ssaków
PT2453912T (pt) Composição para tratamento de leishmaníase canina e humana
PT2461816E (pt) Utilização do xénon para tratar a hipersensibilidade à dor
EP2367555A4 (en) REGENERATION AND REINFORCEMENT OF THE DEVELOPMENT OF MUSCLE TISSUE